chr1-214646756-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016343.4(CENPF):​c.7186A>G​(p.Asn2396Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.463 in 1,612,922 control chromosomes in the GnomAD database, including 185,145 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 12355 hom., cov: 33)
Exomes 𝑓: 0.47 ( 172790 hom. )

Consequence

CENPF
NM_016343.4 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.224

Publications

27 publications found
Variant links:
Genes affected
CENPF (HGNC:1857): (centromere protein F) This gene encodes a protein that associates with the centromere-kinetochore complex. The protein is a component of the nuclear matrix during the G2 phase of interphase. In late G2 the protein associates with the kinetochore and maintains this association through early anaphase. It localizes to the spindle midzone and the intracellular bridge in late anaphase and telophase, respectively, and is thought to be subsequently degraded. The localization of this protein suggests that it may play a role in chromosome segregation during mitotis. It is thought to form either a homodimer or heterodimer. Autoantibodies against this protein have been found in patients with cancer or graft versus host disease. [provided by RefSeq, Jul 2008]
CENPF Gene-Disease associations (from GenCC):
  • Stromme syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Illumina, Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.8148293E-4).
BP6
Variant 1-214646756-A-G is Benign according to our data. Variant chr1-214646756-A-G is described in ClinVar as Benign. ClinVar VariationId is 1209678.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.514 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CENPFNM_016343.4 linkc.7186A>G p.Asn2396Asp missense_variant Exon 13 of 20 ENST00000366955.8 NP_057427.3 P49454
CENPFXM_017000086.3 linkc.7186A>G p.Asn2396Asp missense_variant Exon 13 of 20 XP_016855575.1 P49454
CENPFXM_011509082.4 linkc.7186A>G p.Asn2396Asp missense_variant Exon 13 of 19 XP_011507384.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CENPFENST00000366955.8 linkc.7186A>G p.Asn2396Asp missense_variant Exon 13 of 20 1 NM_016343.4 ENSP00000355922.3 P49454
CENPFENST00000706765.1 linkc.7186A>G p.Asn2396Asp missense_variant Exon 13 of 19 ENSP00000516538.1 A0A9L9PXU7

Frequencies

GnomAD3 genomes
AF:
0.360
AC:
54767
AN:
152054
Hom.:
12356
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.108
Gnomad AMI
AF:
0.552
Gnomad AMR
AF:
0.329
Gnomad ASJ
AF:
0.497
Gnomad EAS
AF:
0.122
Gnomad SAS
AF:
0.311
Gnomad FIN
AF:
0.446
Gnomad MID
AF:
0.379
Gnomad NFE
AF:
0.519
Gnomad OTH
AF:
0.380
GnomAD2 exomes
AF:
0.391
AC:
97511
AN:
249190
AF XY:
0.402
show subpopulations
Gnomad AFR exome
AF:
0.0980
Gnomad AMR exome
AF:
0.261
Gnomad ASJ exome
AF:
0.494
Gnomad EAS exome
AF:
0.117
Gnomad FIN exome
AF:
0.452
Gnomad NFE exome
AF:
0.512
Gnomad OTH exome
AF:
0.428
GnomAD4 exome
AF:
0.474
AC:
691912
AN:
1460750
Hom.:
172790
Cov.:
39
AF XY:
0.472
AC XY:
342742
AN XY:
726696
show subpopulations
African (AFR)
AF:
0.0904
AC:
3019
AN:
33406
American (AMR)
AF:
0.268
AC:
11939
AN:
44580
Ashkenazi Jewish (ASJ)
AF:
0.493
AC:
12856
AN:
26088
East Asian (EAS)
AF:
0.134
AC:
5325
AN:
39688
South Asian (SAS)
AF:
0.326
AC:
28063
AN:
86090
European-Finnish (FIN)
AF:
0.448
AC:
23914
AN:
53352
Middle Eastern (MID)
AF:
0.401
AC:
2306
AN:
5756
European-Non Finnish (NFE)
AF:
0.520
AC:
577744
AN:
1111464
Other (OTH)
AF:
0.443
AC:
26746
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
19122
38244
57366
76488
95610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16102
32204
48306
64408
80510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.360
AC:
54768
AN:
152172
Hom.:
12355
Cov.:
33
AF XY:
0.355
AC XY:
26404
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.108
AC:
4487
AN:
41528
American (AMR)
AF:
0.328
AC:
5018
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.497
AC:
1722
AN:
3464
East Asian (EAS)
AF:
0.122
AC:
631
AN:
5180
South Asian (SAS)
AF:
0.312
AC:
1508
AN:
4828
European-Finnish (FIN)
AF:
0.446
AC:
4714
AN:
10570
Middle Eastern (MID)
AF:
0.384
AC:
112
AN:
292
European-Non Finnish (NFE)
AF:
0.519
AC:
35271
AN:
67992
Other (OTH)
AF:
0.379
AC:
803
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1573
3146
4718
6291
7864
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.461
Hom.:
86066
Bravo
AF:
0.339
TwinsUK
AF:
0.504
AC:
1870
ALSPAC
AF:
0.521
AC:
2007
ESP6500AA
AF:
0.118
AC:
521
ESP6500EA
AF:
0.509
AC:
4376
ExAC
AF:
0.390
AC:
47300
Asia WGS
AF:
0.201
AC:
704
AN:
3478
EpiCase
AF:
0.512
EpiControl
AF:
0.507

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Stromme syndrome Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
9.5
DANN
Benign
0.77
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.77
FATHMM_MKL
Benign
0.32
N
LIST_S2
Benign
0.57
T
MetaRNN
Benign
0.00028
T
MetaSVM
Benign
-0.92
T
PhyloP100
0.22
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.80
N
REVEL
Benign
0.14
Sift
Benign
0.55
T
Sift4G
Benign
0.70
T
Vest4
0.026
MPC
0.059
ClinPred
0.012
T
GERP RS
4.0
Varity_R
0.055
gMVP
0.045
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3748697; hg19: chr1-214820099; COSMIC: COSV65272888; COSMIC: COSV65272888; API